Compare REZI & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | REZI | ADMA |
|---|---|---|
| Founded | 2018 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Wholesale Distributors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 4.7B |
| IPO Year | N/A | N/A |
| Metric | REZI | ADMA |
|---|---|---|
| Price | $35.95 | $16.38 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $34.67 | $28.50 |
| AVG Volume (30 Days) | 1.4M | ★ 2.3M |
| Earning Date | 02-24-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 205.35 |
| EPS | N/A | ★ 0.86 |
| Revenue | ★ $7,435,000,000.00 | $488,559,000.00 |
| Revenue This Year | $12.07 | $22.13 |
| Revenue Next Year | $3.63 | $24.15 |
| P/E Ratio | ★ N/A | $19.19 |
| Revenue Growth | 15.45 | ★ 27.63 |
| 52 Week Low | $14.18 | $13.50 |
| 52 Week High | $45.29 | $25.67 |
| Indicator | REZI | ADMA |
|---|---|---|
| Relative Strength Index (RSI) | 51.80 | 39.66 |
| Support Level | $34.02 | $15.79 |
| Resistance Level | $36.93 | $18.00 |
| Average True Range (ATR) | 1.34 | 0.71 |
| MACD | 0.04 | -0.06 |
| Stochastic Oscillator | 65.72 | 24.40 |
Resideo Technologies Inc is a manufacturer and developer of technology-driven products and components that provide critical comfort, energy management, and safety and security solutions. The company has two reportable segments; Products and Solutions segment offers temperature and humidity control, energy products and solutions, water and air solutions, smoke and carbon monoxide detection home safety products, security panels, sensors, peripherals, wire and cable, communications devices, video cameras, other home-related lifestyle convenience solutions; and ADI Global Distribution segment includes wholesale distributor of low-voltage security products including access control, fire detection, security, and video products. It derives majority of its revenue from the United States.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.